Wafer inspection, the science of finding killer defects in chips, is reaching a critical juncture. Optical inspection, the workhorse technology in the fab, is being stretched to the limit at advanced ...
The multi-beam e-beam mask writer business is heating up, as Intel and NuFlare have separately entered the emerging market. In one surprising move, Intel is in the process of acquiring IMS ...
It has been about a month since the last earnings report for Beam Therapeutics Inc. (BEAM). Shares have added about 5.7% in that time frame, underperforming the S&P 500. Will the recent positive trend ...
It has been about a month since the last earnings report for Beam Therapeutics Inc. (BEAM). Shares have added about 15.9% in that time frame, outperforming the S&P 500. But investors have to be ...
Beam Therapeutics Inc. BEAM announced that the FDA has lifted its clinical hold on the investigational new drug (“IND”) application for BEAM-201 for the treatment of relapsed/refractory T-cell acute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results